Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience

類似資料

• Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature
  著者:: Prelaj, Arsela, 等
  出版事項: (2019)
• Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study
  著者:: Addeo, Raffaele, 等
  出版事項: (2019)
• Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
  著者:: Santoni, Matteo, 等
  出版事項: (2013)
• P17.69 FOTEMUSTINE TRATMENT: WHAT ABOUT GLIOBLASTOMA PATIENTS' QUALITY OF LIFE?
  著者:: Petruzzi, A., 等
  出版事項: (2014)
• Clinical management of grade III oligodendroglioma
  著者:: Simonetti, G, 等
  出版事項: (2015)